ISRCTN85575959Completed未知
A phase III, multicentre, single blind, randomised controlled trial in the use of hyperbaric oxygen therapy versus biofeedback therapy in patients with chronic faecal incontinence associated with pudendal neuropathy
Department of Health (UK)0 sites100 target enrollmentStarted: September 12, 2003Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •100 patients, 50 on each arm.
Exclusion Criteria
- •Not provided at time of registration
Investigators
Similar Trials
Active, not recruiting
Not Applicable
A Phase III multicenter, single blind, randomized, comparative, add?on clinical trial, in three parallel groups, to evaluate the efficacy and safety of a new therapy with adipose?derived autologous stem cells for the treatment of complex perianal fistulas in patients without inflammatory bowel disease FATT I: Fistula Advanced Therapy Trial (I) - FATT 1Treatment of complex perianal fistulas in patients without inflammatory bowel disease.MedDRA version: 8.1Level: LLTClassification code 10002156Term: Anal fistulaEUCTR2006-003370-95-DECELLERIX, S.L.207
Active, not recruiting
Not Applicable
A Phase III multicenter, single blind, randomized, comparative, add?on clinical trial, in three parallel groups, to evaluate the efficacy and safety of a new therapy with adipose?derived autologous stem cells for the treatment of complex perianal fistulas in patients without inflammatory bowel disease FATT I: Fistula Advanced Therapy Trial (I) - FATT 1Treatment of complex perianal fistulas in patients without inflammatory bowel disease.MedDRA version: 8.1Level: LLTClassification code 10002156Term: Anal fistulaEUCTR2006-003370-95-NLCELLERIX, S.L.207
Active, not recruiting
Phase 1
A Phase III multicenter, single blind, randomized, comparative, add?on clinical trial, in three parallel groups, to evaluate the efficacy and safety of a new therapy with adipose?derived autologous stem cells for the treatment of complex perianal fistulas in patients without inflammatory bowel disease FATT I: Fistula Advanced Therapy Trial (I)EUCTR2006-003370-95-ESCELLERIX, S.L.207
Completed
Phase 3
Comparison of Olmesartan +Amlodipine +Hydrochlorothiazide combination with Olmesartan +Hydrochlorothiazide combination in essential hypertension.CTRI/2010/091/006071Aristo Pharmaceuticals Pvt. Ltd. 23-Off veera desai road, Andheri W Mumbai-400053220
Active, not recruiting
Phase 1
A multicenter clinical trial to compare the efficacy and safety of Casirivimab and Imdevimab or Bamlanivimab and Etesevimab or Sotrovimab in high risk COVID-19 hospital admission patients.Mild to moderate COVID-19 patients at high risk of progression to severe COVID-19 and / or hospitalizationMedDRA version: 23.1Level: PTClassification code 10084460Term: COVID-19 treatmentSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2021-004266-35-ITAZIENDA OSPEDALIERO-UNIVERSITARIA DI MODENA552